All patients (n = 58) | |
---|---|
Demographics | |
Age (years) | 53 ± 14 |
Women, n(%) | 43 (74%) |
Time of PH Diagnosis | |
Prior to CMR study | 38 (66%) |
After CMR study | 20 (34%) |
WHO Categorizations | |
WHO Group I | 44 (76%) |
Idiopathic PAH | 24 |
Associated PAH | 20 |
WHO Group II | 8 (14%) |
WHO Group III | 1 (1.7%) |
WHO Group IV | 2 (3.4%) |
WHO Group V | 3 (5.2%) |
Medications at time of CMR | |
Prostacyclin analogs ± other* PH medications | 18 (31%) |
Other* PH medications only | 18 (31%) |
No PH medications | 22 (38%) |